对比剂对CT辐射剂量的影响:第一部分——将对比剂动力学纳入人体模型体模
研究将患者特异性生理药代动力学模型纳入58个XCAT人体模型体模,模拟对比剂在体内的动态分布,构建对比剂增强的五维XCAT模型,并与已发表临床数据比较验证准确性,多数增强参数差异小于10%至14%,仅单相注射方案肝增强差异小于25%。
要点
- 开发了将对比剂动态分布纳入XCAT人体模型体模的方法,可用于模拟对比剂增强CT检查。
- 模拟的主动脉和肝脏对比增强结果与已发表临床数据总体一致,多数差异小于10%至14%。
- 单相注射方案下肝脏增强计算的差异小于25%,为唯一例外。
核心结论
- 开发了一种在XCAT人体模型中模拟对比剂分布的技术,所构建的含对比剂动态分布的模型可应用于模拟对比剂增强CT检查。
研究设计与样本
- 方法学研究,将患者特异性生理药代动力学模型纳入58个XCAT患者体模,每个体模具有独特的血管和器官隔室模型,通过碘质量平衡微分方程求解获得各隔室对比剂浓度时间曲线,并与已发表临床数据比较验证。
诊断标准与关键数值
- 单相注射方案:模拟与临床数据的平均差异百分比小于10%(P > .74)、达90%峰值时间差异小于4%、峰值差异小于7%、增强斜率差异小于14%。
- 双相注射方案:模拟与临床数据的平均差异百分比小于12%(P > .56)、达90%峰值时间差异小于4%、峰值差异小于12%、增强斜率差异小于14%。
- 单相注射方案下肝脏增强计算结果的差异小于25%(例外)。
局限性
- 单相注射方案下肝脏增强计算结果的差异小于25%,为原文报告的唯一例外。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To develop a method to incorporate the propagation of contrast material into computational anthropomorphic phantoms for estimation of organ dose at computed tomography (CT). Materials and Methods A patient-specific physiologically based pharmacokinetic (PBPK) model of the human cardiovascular system was incorporated into 58 extended cardiac-torso (XCAT) patient phantoms. The PBPK model comprised compartmental models of vessels and organs unique to each XCAT model. For typical injection protocols, the dynamics of the contrast material in the body were described according to a series of patient-specific iodine mass-balance differential equations, the solutions to which provided the contrast material concentration time curves for each compartment. Each organ was assigned to a corresponding time-varying iodinated contrast agent to create the contrast material-enhanced five-dimensional XCAT models, in which the fifth dimension represents the dynamics of contrast material. To validate the accuracy of the models, simulated aortic and hepatic contrast-enhancement results throughout the models were compared with previously published clinical data by using the percentage of discrepancy in the mean, time to 90% peak, peak value, and slope of enhancement in a paired t test at the 95% significance level. Results The PBPK model allowed effective prediction of the time-varying concentration curves of various contrast material administrations in each organ for different patient models. The contrast-enhancement results were in agreement with results of previously published clinical data, with mean percentage, time to 90% peak, peak value, and slope of less than 10% (P > .74), 4%, 7%, and 14% for uniphasic and 12% (P > .56), 4%, 12%, and 14% for biphasic injection protocols, respectively. The exception was hepatic enhancement results calculated for a uniphasic injection protocol for which the discrepancy was less than 25%. Conclusion A technique to model the propagation of contrast material in XCAT human models was developed. The models with added contrast material propagation can be applied to simulate contrast-enhanced CT examinations. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Sahbaee P, Segars WP, Marin D, et al. The Effect of Contrast Material on Radiation Dose at CT: Part I. Incorporation of Contrast Material Dynamics in Anthropomorphic Phantoms. Radiology. 2017. PMID: 28092496. doi:10.1148/radiol.2016152851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。